Published on in Vol 10, No 3 (2022): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/32313, first published .
Predicting Long-term Survival After Allogeneic Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies: Machine Learning–Based Model Development and Validation

Predicting Long-term Survival After Allogeneic Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies: Machine Learning–Based Model Development and Validation

Predicting Long-term Survival After Allogeneic Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies: Machine Learning–Based Model Development and Validation

Journals

  1. Afanaseva K, Bakin E, Smirnova A, Barkhatov I, Gindina T, Moiseev I, Bondarenko S. A pilot study of implication of machine learning for relapse prediction after allogeneic stem cell transplantation in adults with Ph-positive acute lymphoblastic leukemia. Scientific Reports 2023;13(1) View
  2. Qu Y, Shourabizadeh H, Subramanian A, Aleman D, Rousseau L, Law A, Viswabandya A, Michelis F. Differential impact of CD34+ cell dose for different age groups in allogeneic hematopoietic cell transplantation for acute leukemia: a machine learning–based discovery. Experimental Hematology 2025;141:104684 View

Books/Policy Documents

  1. Hanselia R, Choubey D. International Conference on Innovative Computing and Communications. View